The Retinoblastoma Protein Is Linked to the Activation of Ras

REFERENCES

• Bader, D., T. Masaki, and J. Fischman 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763–770.
   PubMed Web of Science ®Google Scholar
• Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56:779–827.
   PubMed Web of Science ®Google Scholar
• Bourne, H. R., D. A. Sanders, and J. McCormick 1990. The GTPase superfamily: a conserved switch for diverse functions. Nature 348:125–132.
   PubMed Web of Science ®Google Scholar
• Brooks, R. F. 1977. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12:311–317.
   PubMed Web of Science ®Google Scholar
• Chen, P.-L., D. J. Riley, Y. Chen, and J. Lee 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794–2804.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, S. Chen-Kiang, and J. Lee 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 93:465–469.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, and J. Lee 1995. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukaryot. Gene Expr. 5:79–95.
   PubMedGoogle Scholar
• Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and J. Riele 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328–330.
   PubMed Web of Science ®Google Scholar
• Coppola, J. A., B. A. Lewis, and J. Cole 1990. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5:1731–1733.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, J. Figge, J.-Y. Shew, C.-M. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and J. Livingston 1988. SV40 large T antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283.
   PubMed Web of Science ®Google Scholar
• Downward, J. 1997. Cell cycle: routine role for Ras. Curr. Biol. 7:R258–R260.
   PubMed Web of Science ®Google Scholar
• Downward, J., J. D. Graves, P. H. Warne, S. Rayter, and J. Cantrell 1990. Stimulation of p21ras upon T-cell activation. Nature 346:719–723.
   PubMed Web of Science ®Google Scholar
• Dryja, T. P., J. Rapaport, T. L. McGee, T. M. Nork, and J. Schwartz 1993. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am. J. Genet. 52:1122–1128.
   Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Dyson, N., K. Guida, K. Munger, and J. Harlow 1989. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.
   PubMed Web of Science ®Google Scholar
• Endo, T., and J. Goto 1992. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J. Biochem. 112:427–430.
   PubMedGoogle Scholar
• Ewen, M. E. 1998. Regulation of the cell cycle by the Rb tumor suppressor family Cell cycle control In M. Pagano (ed.), 22:149–179 Springer-Verlag, Heidelberg, Germany.
   Google Scholar
• Feig, L. A., and J. Cooper 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235–3243.
   PubMed Web of Science ®Google Scholar
• Gigure, V., S. Hollenberg, M. Rosenfeld, and J. Evans 1986. Functional domains of the human glucocorticoid receptor. Cell 46:645–652.
   PubMedGoogle Scholar
• Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and J. Nadal-Ginard 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309–324.
   PubMed Web of Science ®Google Scholar
• Hock, J. R., A. Ziemiecki, R. Klemenz, R. Friis, and J. Groner 1989. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels. Cancer Res. 49:2266s–2274s.
   PubMedGoogle Scholar
• Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and J. Weinberg 1992. Effects of an Rb mutation in the mouse. Nature 359:295–300.
   PubMed Web of Science ®Google Scholar
• Kitzmann, M., G. Carnac, M. Vandromme, M. Primig, N. J. C. Lamb, and J. Fernandez 1998. The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle-specific expression in muscle cells. J. Cell Biol. 142:1447–1459.
   PubMed Web of Science ®Google Scholar
• Kong, Y., S. E. Johnson, E. J. Taparowsky, and J. Konieczny 1995. Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15:5205–5213.
   PubMedGoogle Scholar
• Kratzke, R. A., G. A. Otterson, A. Hogg, A. B. Coxon, J. Geradts, J. K. Cowell, and J. Kaye 1994. Partial inactivation of RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9:1321–1326.
   PubMed Web of Science ®Google Scholar
• Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and J. Ewen 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18:6605–6615.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and J. Bradley 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288–294.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y.-H. P., N. Hu, S.-S. F. Yuan, L. A. Cox, A. Bradley, W.-H. Lee, and J. Herrup 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008–2021.
   PubMed Web of Science ®Google Scholar
• Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. Nevins 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422–426.
   PubMed Web of Science ®Google Scholar
• Lohmann, D. R., B. Brandt, W. Hopping, E. Passarge, and J. Horsthemke 1994. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum. Genet. 94:349–354.
   PubMed Web of Science ®Google Scholar
• Lu, X., and J. Horvitz 1998. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell 95:981–991.
   PubMedGoogle Scholar
• Lukas, J., J. Bartkova, M. Rohde, M. Strauss, and J. Bartek 1995. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600–2611.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., and J. Pellicer 1998. Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3:d887–d912.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and J. Caruso 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 1994:3579–3590.
   Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., H. Paterson, M. F. Olson, and J. Marshall 1997. Ras signalling is required for inactivation of tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7:219–221.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and J. Lassar 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441–456.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., D. B. Spicer, P. S. Kim, W. L. Cheung, and J. Lassar 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449–459.
   PubMed Web of Science ®Google Scholar
• Olson, E. N., G. Spizz, and J. Tainsky 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104–2111.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603–608.
   PubMed Web of Science ®Google Scholar
• Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and J. Reeves 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62–67.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and J. Baltimore 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and J. Ewen 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177–181.
   PubMed Web of Science ®Google Scholar
• Pronk, G. J., and J. Bos 1994. The role of p21ras in receptor tyrosine kinase signalling. Biochim. Biophys. Acta 1198:131–147.
   PubMedGoogle Scholar
• Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and J. Sherr 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559–1571.
   PubMed Web of Science ®Google Scholar
• Ramocki, M. B., S. E. Johnson, M. A. White, C. L. Ashendel, S. F. Konieczny, and J. Taparowsky 1997. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17:3547–3555.
   PubMed Web of Science ®Google Scholar
• Raptis, L., H. L. Brownell, M. J. Corbley, K. W. Wood, D. Wang, and J. Haliotis 1997. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40. Cell Growth Differ. 8:891–901.
   PubMedGoogle Scholar
• Resnitzky, D., and J. Reed 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:3463–3469.
   PubMed Web of Science ®Google Scholar
• Schlessinger, J., and J. Bar-Sagi 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harbor Symp. Quant. Biol. 59:173–179.
   PubMedGoogle Scholar
• Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and J. Nadal-Ginard 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264:1467–1471.
   PubMed Web of Science ®Google Scholar
• Screpanti, V. A., M. Maroder, E. Petrangeli, L. Frati, and J. Gulino 1989. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. Mol. Endocrinol. 3:1659–1665.
   PubMedGoogle Scholar
• Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and J. Kaelin 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor growth. Genes Dev. 12:96–106.
   Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sieburth, D. S., Q. Sun, and J. Han 1998. SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 94:119–130.
   PubMed Web of Science ®Google Scholar
• Singh, P., J. Coe, and J. Hong 1995. A role for the retinoblastoma protein in potentiating transcriptional activation of the glucocorticoid receptor. Nature 374:562–565.
   PubMedGoogle Scholar
• Taylor, S. J., and J. Shalloway 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621–1627.
   PubMed Web of Science ®Google Scholar
• Todaro, G. J., and J. Green 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299–313.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Whitaker, L. L., H. Su, R. Baskaran, E. S. Knudsen, and J. Wang 1998. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol. Cell. Biol. 18:4032–4042.
   PubMed Web of Science ®Google Scholar
• Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68:1041–1050.
   PubMed Web of Science ®Google Scholar
• Zacksenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and J. Gallie 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:3051–3064.
   PubMed Web of Science ®Google Scholar
• Zalvide, J., and J. DeCaprio 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800–5810.
   PubMedGoogle Scholar